Document is current
Any future updates will be listed below
-
Authors
Lange, Fabienne https://orcid.org/0000-0003-2707-7676
Geppert, Carol I.
Bahlinger, Veronika
Bertz, Simone
Stöhr, Robert
Sikic, Danijel
Taubert, Helge
Wach, Sven
Wullich, Bernd
Hartmann, Arndt
Eckstein, Markus
-
Funding
Funding for this research was provided by:
Universitätsklinikum Erlangen
- License Information
-
More Information
Article History
Received: 7 April 2024
Revised: 10 June 2024
Accepted: 9 July 2024
First Online: 19 July 2024
Declarations
:
: FL reports no conflict of interest.CG reports speaker’s honoraria from Sysmex.VB reports speaker’s honoraria from MSD and Biocartis and reports research funding from Gilead.SB reports no conflict of interest.RS reports no conflict of interest.DS reports no conflict of interest.HT reports speaker honoraria from Qiagen.SW reports no conflict of interest.BW reports speaker’s honoraria from Astellas, Janssen-Cilag, and MSD.AH reports honoraria for lectures for Eisai, Abbvie, AstraZeneca, Biontech, BMS, Boehringer Ingelheim, Cepheid, Diaceutics, Ipsen, Janssen, Lilly, MSD, Nanostring, Novartis, Roche, and 3DHistotech; advisory role for Abbvie, AstraZeneca, Biontech, BMS, Boehringer Ingelheim, Cepheid, Diaceutics, Gilead, Illumina, Ipsen, Janssen, Lilly, MSD, Nanostring, Novartis, Qiagen, QUIP GmbH, Roche, and 3DHistotech; and research funding from AstraZeneca, Biontech, Cepheid, Gilead, Illumina, Janssen, Nanostring, Qiagen, QUIP GmbH, Roche, STRATIFYER, and Owkin.ME reports speaker’s honoraria from Eisai, Roche, Astellas, MSD, AstraZeneca, Janssen-Cilag, Cepheid, and Diaceutics; reports research funding from STRATIFYER, AstraZeneca, Janssen-Cilag, Gilead Sciences, Cepheid, and Owkin; reports advisory honoraria from AstraZeneca, Janssen-Cilag, GenomicHealth, Cepheid, and Diaceutics; and reports a part time employment as scientific advisor for Diaceutics.
